185 related articles for article (PubMed ID: 31281982)
1. Adipocyte Fatty Acid-Binding Protein as a Novel Marker of Psoriasis and Clinical Response to Acitretin.
Baran A; Kiluk P; Świderska M; Maciaszek M; Myśliwiec H; Flisiak I
Lipids; 2019 Aug; 54(8):445-452. PubMed ID: 31281982
[TBL] [Abstract][Full Text] [Related]
2. Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis.
Baran A; Kiluk P; Maciaszek M; Świderska M; Flisiak I
Arch Dermatol Res; 2019 Jul; 311(5):389-397. PubMed ID: 30993401
[TBL] [Abstract][Full Text] [Related]
3. Serum Fatty Acid-Binding Protein 4 is Increased in Patients with Psoriasis.
Baran A; Świderska M; Bacharewicz-Szczerbicka J; Myśliwiec H; Flisiak I
Lipids; 2017 Jan; 52(1):51-60. PubMed ID: 27864793
[TBL] [Abstract][Full Text] [Related]
4. Serum irisin levels in patients with psoriasis.
Baran A; Myśliwiec H; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2017 Jun; 28(4):304-308. PubMed ID: 27786588
[TBL] [Abstract][Full Text] [Related]
5. Serum fatty acid binding protein 5 (FABP5) as a potential biomarker of inflammation in psoriasis.
Kozłowska D; Myśliwiec H; Harasim-Symbor E; Milewska AJ; Chabowski A; Flisiak I
Mol Biol Rep; 2021 May; 48(5):4421-4429. PubMed ID: 34131888
[TBL] [Abstract][Full Text] [Related]
6. Plasma miR-126 expression correlates with risk and severity of psoriasis and its high level at baseline predicts worse response to Tripterygium wilfordii Hook F in combination with acitretin.
Duan Y; Zou J; Mao J; Guo D; Wu M; Xu N; Zhou J; Zhang Y; Guo W; Jin W
Biomed Pharmacother; 2019 Jul; 115():108761. PubMed ID: 31100542
[TBL] [Abstract][Full Text] [Related]
7. The association of serum adipocyte fatty acid-binding protein with coronary artery disease in Korean adults.
Rhee EJ; Lee WY; Park CY; Oh KW; Kim BJ; Sung KC; Kim BS
Eur J Endocrinol; 2009 Feb; 160(2):165-72. PubMed ID: 19001529
[TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
Akçali C; Guven EH; Kirtak N; Inaloz HS; Ozgoztasi O; Guvenc U
J Int Med Res; 2014 Oct; 42(5):1118-22. PubMed ID: 25143337
[TBL] [Abstract][Full Text] [Related]
9. The role of serum adipocyte fatty acid-binding protein on the development of metabolic syndrome is independent of pro-inflammatory cytokines.
Park SE; Rhee EJ; Lee WY; Kim WJ; Yoo SH; Bae JC; Choi ES; Park CY; Oh KW; Park SW; Kim SW
Nutr Metab Cardiovasc Dis; 2012 Jun; 22(6):525-32. PubMed ID: 21186114
[TBL] [Abstract][Full Text] [Related]
10. Lp-PLA2 as a promising predictor of comorbidities in patients with severe psoriasis.
Kiluk P; Baran A; Świderska M; Maciaszek M; Flisiak I
J Dermatolog Treat; 2020 Aug; 31(5):524-530. PubMed ID: 30998429
[No Abstract] [Full Text] [Related]
11. Adipose-Derived Fatty Acid-Binding Proteins Plasma Concentrations Are Increased in Breast Cancer Patients.
Guaita-Esteruelas S; Saavedra-García P; Bosquet A; Borràs J; Girona J; Amiliano K; Rodríguez-Balada M; Heras M; Masana L; Gumà J
Oncologist; 2017 Nov; 22(11):1309-1315. PubMed ID: 28701570
[TBL] [Abstract][Full Text] [Related]
12. FABP 4 is associated with inflammatory markers and metabolic syndrome in morbidly obese women.
Terra X; Quintero Y; Auguet T; Porras JA; Hernández M; Sabench F; Aguilar C; Luna AM; Del Castillo D; Richart C
Eur J Endocrinol; 2011 Apr; 164(4):539-47. PubMed ID: 21257725
[TBL] [Abstract][Full Text] [Related]
13. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
[TBL] [Abstract][Full Text] [Related]
14. The effect of topical treatment and psoriasis severity on serum retinol-binding protein-4 levels.
Baran A; Swiderska M; Flisiak I
J Dermatolog Treat; 2016; 27(2):114-9. PubMed ID: 26293108
[TBL] [Abstract][Full Text] [Related]
15. Effect of psoriasis activity and topical treatment on serum lipocalin-2 levels.
Baran A; Świderska M; Myśliwiec H; Flisiak I
J Dermatolog Treat; 2017 Mar; 28(2):136-140. PubMed ID: 27165470
[TBL] [Abstract][Full Text] [Related]
16. Circulating Adipocyte Fatty Acid Binding Protein (FABP4) Levels Are Associated with Irisin in the Middle-Aged General Chinese Population.
Zhang S; Yang L; Chen P; Jin H; Xie X; Yang M; Gao T; Hu C; Yu X
PLoS One; 2016; 11(1):e0146605. PubMed ID: 26752184
[TBL] [Abstract][Full Text] [Related]
17. Plasma fatty acid-binding protein 4 (FABP4) level is associated with abnormal QTc interval in patients with stable angina and chronic kidney disease.
Wang CP; Hsu CC; Hung WC; Yu TH; Wu CC; Tsai IT; Tang WH; Chung FM; Houng JY; Lee YJ; Lu YC
BMC Cardiovasc Disord; 2019 Jun; 19(1):153. PubMed ID: 31234795
[TBL] [Abstract][Full Text] [Related]
18. The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin.
Kuijpers AL; Van Pelt JP; Bergers M; Boegheim PJ; Den Bakker JE; Siegenthaler G; Van de Kerkhof PC; Schalkwijk J
Br J Dermatol; 1998 Sep; 139(3):380-9. PubMed ID: 9988537
[TBL] [Abstract][Full Text] [Related]
19. The effect of acitretin treatment on insulin resistance, retinol-binding protein-4, leptin, and adiponectin in psoriasis vulgaris: a noncontrolled study.
Karadag AS; Ertugrul DT; Kalkan G; Bilgili SG; Celik HT; Takci Z; Balahoroglu R; Calka O
Dermatology; 2013; 227(2):103-8. PubMed ID: 24021889
[TBL] [Abstract][Full Text] [Related]
20. Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitus.
Ning H; Tao H; Weng Z; Zhao X
Acta Diabetol; 2016 Dec; 53(6):891-898. PubMed ID: 27147422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
